ZeJing Pharmaceuticals (688266.SH) is planning to issue H shares and list on the Hong Kong Stock Exchange.

Zhijia Finance and Economics APP News, Zejing Pharmaceutical (688266.SH) announced that, in order to meet the needs of the company's internationalization strategy and overseas business layout, enhance the company's international brand awareness, and increase the overall competitiveness of the company, the company plans to issue overseas listed shares (H shares) and apply for listing on the main board of The Stock Exchange of Hong Kong Limited (referred to as "Hong Kong Stock Exchange").